American college of endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control

Endocrine Practice

Volumn 12, Issue 4, 2006, Pages 458-467

  Clark, Nathaniel G ^a   Fonseca, Vivian ^a   Garber, Alan J ^a   Inzucchi, Silvio E ^a   Moghissi, Etie S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSENSUS DEVELOPMENT; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEART INFARCTION; HOSPITAL MANAGEMENT; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; INTENSIVE CARE UNIT; META ANALYSIS; MONOTHERAPY; MORTALITY; POSTOPERATIVE CARE; QUALITY OF LIFE; REVIEW; RISK FACTOR; ST SEGMENT ELEVATION; TREATMENT OUTCOME; CONFERENCE PAPER; ECONOMICS; HEALTH CARE QUALITY; HOSPITAL PATIENT; HOSPITALIZATION; QUESTIONNAIRE;

BLOOD GLUCOSE; DIABETES MELLITUS; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; INPATIENTS; QUALITY OF HEALTH CARE; QUESTIONNAIRES;

EID: 33750111805     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29:1263-1268.
2. Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE. Unrecognized diabetes among hospitalized patients. Diabetes Care. 1998;21:246-249.
3. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-982.
4. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Rev ed. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2004. Available at: www.cdc.gov/diabetes/Pubs/factsheet.htm. Accessed for verification June 5, 2006.
5. Hogan P, Dall T, Nikolov P (American Diabetes Association). Economic cost of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.
6. Garber AJ, Moghissi ES, Bransome ED Jr, et al (American College of Endocrinology Task Force on Inpatient Diabetes and Metabolic Control). American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004; 10(Suppl 2):4-9.
7. Clement S, Braithwaite SS, Magee MF, et al (American Diabetes Association Diabetes in Hospitals Writing Committee). Management of diabetes and hyperglycemia in hospitals [errata in Diabetes Care. 204;27:856 and Diabetes Care 2004;27:1255]. Diabetes Care. 2004;27: 553-591.
8. American Diabetes Association. Standards of medical care in diabetes [erratum in Diabetes Care. 2005;28:990]. Diabetes Care. 2005;28(Suppl 1):S4-S36.
9. Malmberg K (DIGAMI [Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction] Study Group). Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
10. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures [with discussion]. Ann Thorac Surg. 1999;67:352-362.
11. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
12. Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125:1007-1021.
13. Krinsley JS. Effect of intensive glucose management protocol on the mortality of critically ill adult patients [erratum in Mayo Clin Proc. 2005;80:1101]. Mayo Clin Proc. 2004;79:992-1000.
14. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized, controlled trials. Arch Intern Med. 2004; 164:2005-2011.
15. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction; long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999;99:2626-2632.
16. Sala J, Masia R, Gonzalez de Molina FJ, et al (REGI-COR Investigators). Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission. J Epidemiol Community Health. 2002;56:707-712.
17. Latham R, Lancaster AD, Covington JF, Pirolo, JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol. 2001;22: 607-612.
18. Ishihara M, Kojima S, Sakamoto T, et al (Japanese Acute Coronary Syndrome Study Investigators). Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J. 2005;150:814-820.
19. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
20. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005; 111:3078-3086.
21. Timmer JR, van der Horst IC, Ottervanger JP, et al (Zwolle Myocardial Infarction Study Group). Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J. 2004; 148:399-404.
22. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
23. Malmberg K, Ryden L, Wedel H, et al (DIGAMI 2 Investigators). Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-661.
24. Mehta SR, Yusuf S, Diaz R, et al (CREATE-ECLA Trial Group Investigators). Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005; 293:437-446.
25. Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22:1408-1414.
26. Pomposelli JJ, Baxter JK III, Babinean TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998;22:77-81.
27. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in non-diabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432.
28. Estrada CA, Young JA, Nifong LW, Chitwood WR Jr. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75:1392-1399.
29. Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma. 2003;55:33-38.
30. Levetan CS, Salas JR, Wilets IF, Zumoff B. Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. Am J Med. 1995;99:22-28.
31. Furnary AP. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland Diabetic Project. Endocr Pract. 2006; 12(Suppl 3):22-26.
32. Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006;34:612-616.
33. Newton CA. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract. 2006; 12(Suppl 3):43-48.
34. Lawrence CB. The benefits of inpatient diabetes care: improving quality of care and the bottom line. Endocr Pract. 2006;12(Suppl 3):35-42.
35. Hellman R. A systems approach to reducing errors in insulin therapy in the inpatient setting. Endocr Pract. 2004;10(Suppl 2):100-108.
36. Smith WD, Winterstein AG, Johns T, Rosenberg E, Sauer BC. Causes of hyperglycemia and hypoglycemia in adult inpatients. Am J Health-Syst Pharm. 2005;62:714-719.
37. Buonocore D. Leadership in action: creating a change in practice. AACN Clin Issues. 2004; 15:170-181.
38. Ku SY, Sayre CA, Hirsch IB, Kelly JL. New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. Jt Comm J Qual Patient Saf. 2005;31:141-147.
39. Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461-467.
40. Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004; 10(Suppl 2):21-33.
41. Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract. 2002;8:10-18.
42. Magee MF, Clement S. Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation. Endocr Pract. 2004;10(Suppl 2):81-88.
43. Greci LS, Kailasam M, Malkani S, et al. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care. 2003;26: 1064-1068.
44. Norhammar A, Tenerz A, Nilsson G, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140-2144.
45. Conaway DG, O'Keefe JH, Reid KJ, Spertus J. Frequency of undiagnosed diabetes mellitus in patients with acute coronary syndrome. Am J Cardiol. 2005;96: 363-365.
46. Bartnik M, Ryden L, Ferrari R, et al (Euro Heart Survey Investigators). The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: the Euro Heart Survey on diabetes and the heart. Eur Heart J. 2004;25:1880-1890.
47. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ. 2001;322:15-18.